Crizotinib: Medgend

Crizotinib FDA Approved Drugs

ALUNBRIG [Brigatinib^{C₂₉H₃₉ClN₇O₂P}]

30mg (oral tablet)

90mg (oral tablet)

Ariad^{Apr 28, 2017}

Treatment of patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc) who have progressed on or are intolerant to crizotinib.

efficacy
3.0 (1)

side effects
0.0 (0)

danger
0.0 (0)

XALKORI [Crizotinib^{C₂₁H₂₂Cl₂FN₅O}]

200mg (oral capsule)

250mg (oral capsule)

Pf Prism Cv^{Aug 26, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.